We are live on
!
Find out more
TOCUITCONY
Trustees of Columbia University in the City of New York Portfolio holdings
AUM
$891M
1-Year Est. Return
17.3%
This Fund
S&P 500
This Quarter
Est. Return
-2.75%
1 Year Est. Return
+17.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.4M
AUM Growth
-$2.31M
(-3.4%)
Cap. Flow
+$2.88M
Cap. Flow
% of AUM
4.41%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
22
New
8
Increased
1
Reduced
2
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Surrozen
SRZN
|
+$6.75M |
| 2 |
Tenaya Therapeutics
TNYA
|
+$6.27M |
| 3 |
CMRC
Commerce.com Inc Series 1
CMRC
|
+$4.9M |
| 4 |
CLDR
Cloudera, Inc.
CLDR
|
+$1.8M |
| 5 |
ONEM
1Life Healthcare
ONEM
|
+$1.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kymera Therapeutics
KYMR
|
+$13.5M |
| 2 |
Asana
ASAN
|
+$2.66M |
| 3 |
Vor Biopharma
VOR
|
+$1.37M |
| 4 |
Microsoft
MSFT
|
+$1.27M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$663K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 49.53% |
| 2 | Healthcare | 36.65% |
| 3 | Technology | 11.06% |
| 4 | Consumer Discretionary | 1.99% |
| 5 | Consumer Staples | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $32.1M | 49.07% |
78
| – | – |
|
2
Sana Biotechnology
SANA
$1.09B
| $6.33M | 9.69% |
281,250
| – | – |
|
|
3
Tenaya Therapeutics
TNYA
$169M
| $6.03M | 9.22% |
+291,828
| New | +$6.27M |
|
|
4
Surrozen
SRZN
$282M
| $5.09M | 7.78% |
+47,930
| New | +$6.75M |
|
|
CMRC
5
Commerce.com Inc Series 1
CMRC
$180M
| $4.07M | 6.23% |
+80,432
| New | +$4.9M |
|
|
RAPT
6
DELISTED
RAPT Therapeutics
RAPT
| $2.28M | 3.49% |
9,173
-603
| -6% | -$159K |
|
|
CLDR
7
DELISTED
Cloudera, Inc.
CLDR
| $1.81M | 2.77% |
+113,458
| New | +$1.8M |
|
|
8
Vor Biopharma
VOR
$1.36B
| $1.44M | 2.2% |
4,596
-4,595
| -50% | -$1.37M |
|
9
Amplitude
AMPL
$1.56B
| $1.35M | 2.06% |
+24,821
| New | +$1.35M |
|
|
SFIX
10
Stitch Fix
SFIX
$487M
| $1.3M | 1.99% |
32,631
+6,979
| +27% | +$326K |
|
|
ONEM
11
DELISTED
1Life Healthcare
ONEM
| $1.18M | 1.8% |
+58,013
| New | +$1.49M |
|
|
KLDO
12
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $820K | 1.25% |
150,150
| – | – |
|
|
EVLO
13
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $802K | 1.23% |
5,693
| – | – |
|
14
Coursera
COUR
$1.49B
| $459K | 0.7% |
+14,490
| New | +$545K |
|
|
15
Berkshire Hathaway Class B
BRK.B
$1.08T
| $300K | 0.46% |
1,100
| – | – |
|
|
SRZNW
16
DELISTED
Surrozen Inc Warrant
SRZNW
| $38K | 0.06% |
+33,333
| New | +$45.8K |
|
|
17
Asana
ASAN
$2.03B
| – | – |
-42,888
| Closed | -$2.66M |
|
|
18
Kymera Therapeutics
KYMR
$9.49B
| – | – |
-278,127
| Closed | -$13.5M |
|
|
19
Microsoft
MSFT
$3.67T
| – | – |
-4,678
| Closed | -$1.27M |
|
20
Progyny
PGNY
$1.99B
| – | – |
-9,808
| Closed | -$579K |
|
21
Snowflake
SNOW
$116B
| – | – |
-1,716
| Closed | -$415K |
|
|
ZEN
22
DELISTED
ZENDESK INC
ZEN
| – | – |
-4,591
| Closed | -$663K |
|
Similar funds
SFM
FCM
SI
FTM
WIC
I
GEM
GGH
Trustees of Columbia University in the City of New York's Q3 2021 Portfolio in Review
As of Q3 2021, Trustees of Columbia University in the City of New York held 22 positions worth $65.4M, down 3.4% from $67.7M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Trustees of Columbia University in the City of New York deployed $2.88M of net new capital in Q3 2021, opening 8 new positions and adding to 1 existing holding. Its largest new stake was Surrozen: 47,930 shares worth $5.09M.
By sector, the portfolio is most concentrated in Financials at 50% of assets, up from 49% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Vor Biopharma, an estimated $1.37M trimmed.
- Trustees of Columbia University in the City of New York's largest Q3 2021 buy was Surrozen: 47,930 shares worth $5.09M.
- Trustees of Columbia University in the City of New York added most to Stitch Fix in Q3 2021, an estimated $326K increase.
- Trustees of Columbia University in the City of New York's biggest Q3 2021 reduction was Vor Biopharma, cutting an estimated $1.37M.
- Trustees of Columbia University in the City of New York fully exited Kymera Therapeutics in Q3 2021, selling an estimated $13.5M.
- Trustees of Columbia University in the City of New York's ten largest holdings make up 95% of its $65.4M portfolio in Q3 2021.
- Trustees of Columbia University in the City of New York opened 8 new positions and closed 6 in Q3 2021.
- Trustees of Columbia University in the City of New York's portfolio value fell 3.4% quarter-over-quarter to $65.4M.
Based on Trustees of Columbia University in the City of New York's 13F filing for Q3 2021, filed 15 Nov 2021.